Literature DB >> 12196661

Mutations of the slow muscle alpha-tropomyosin gene, TPM3, are a rare cause of nemaline myopathy.

D Wattanasirichaigoon1, K J Swoboda, F Takada, H-Q Tong, V Lip, S T Iannaccone, C Wallgren-Pettersson, N G Laing, A H Beggs.   

Abstract

The alpha-tropomyosin-3 (TPM3) gene was screened in 40 unrelated patients with nemaline myopathy (NM). A single compound heterozygous patient was identified carrying one mutation that converts the stop codon to a serine and a second splicing mutation that is predicted to prevent inclusion of skeletal muscle exon IX. TPM3 mutations are a rare cause of NM, probably accounting for less than 3% of cases. The severity of cases with TPM3 mutations may vary from severe infantile to late childhood onset, slowly progressive forms.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12196661     DOI: 10.1212/wnl.59.4.613

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  31 in total

1.  Clinical utility gene card for: nemaline myopathy.

Authors:  Kristen J Nowak; Mark R Davis; Carina Wallgren-Pettersson; Phillipa J Lamont; Nigel G Laing
Journal:  Eur J Hum Genet       Date:  2012-04-18       Impact factor: 4.246

2.  Inhibition of activin receptor type IIB increases strength and lifespan in myotubularin-deficient mice.

Authors:  Michael W Lawlor; Benjamin P Read; Rachel Edelstein; Nicole Yang; Christopher R Pierson; Matthew J Stein; Ariana Wermer-Colan; Anna Buj-Bello; Jennifer L Lachey; Jasbir S Seehra; Alan H Beggs
Journal:  Am J Pathol       Date:  2011-02       Impact factor: 4.307

3.  Skeletal muscle repair in a mouse model of nemaline myopathy.

Authors:  Despina Sanoudou; Mark A Corbett; Mei Han; Majid Ghoddusi; Mai-Anh T Nguyen; Nicole Vlahovich; Edna C Hardeman; Alan H Beggs
Journal:  Hum Mol Genet       Date:  2006-07-28       Impact factor: 6.150

4.  Knockin mouse model of the human CFL2 p.A35T mutation results in a unique splicing defect and severe myopathy phenotype.

Authors:  Samantha M Rosen; Mugdha Joshi; Talia Hitt; Alan H Beggs; Pankaj B Agrawal
Journal:  Hum Mol Genet       Date:  2020-07-29       Impact factor: 6.150

5.  Mutations and polymorphisms of the skeletal muscle alpha-actin gene (ACTA1).

Authors:  Nigel G Laing; Danielle E Dye; Carina Wallgren-Pettersson; Gabriele Richard; Nicole Monnier; Suzanne Lillis; Thomas L Winder; Hanns Lochmüller; Claudio Graziano; Stella Mitrani-Rosenbaum; Darren Twomey; John C Sparrow; Alan H Beggs; Kristen J Nowak
Journal:  Hum Mutat       Date:  2009-09       Impact factor: 4.878

6.  Treatment with ActRIIB-mFc Produces Myofiber Growth and Improves Lifespan in the Acta1 H40Y Murine Model of Nemaline Myopathy.

Authors:  Jennifer Tinklenberg; Hui Meng; Lin Yang; Fujun Liu; Raymond G Hoffmann; Mahua Dasgupta; Kenneth P Allen; Alan H Beggs; Edna C Hardeman; R Scott Pearsall; Robert H Fitts; Michael W Lawlor
Journal:  Am J Pathol       Date:  2016-04-18       Impact factor: 4.307

7.  Clinical utility gene card for: Nemaline myopathy - update 2015.

Authors:  Kristen J Nowak; Mark R Davis; Carina Wallgren-Pettersson; Phillipa J Lamont; Nigel G Laing
Journal:  Eur J Hum Genet       Date:  2015-02-25       Impact factor: 4.246

8.  Autosomal dominant nemaline myopathy caused by a novel alpha-tropomyosin 3 mutation.

Authors:  I C Kiphuth; S Krause; H B Huttner; G Dekomien; T Struffert; R Schröder
Journal:  J Neurol       Date:  2009-12-10       Impact factor: 4.849

9.  Mutations of tropomyosin 3 (TPM3) are common and associated with type 1 myofiber hypotrophy in congenital fiber type disproportion.

Authors:  Michael W Lawlor; Elizabeth T Dechene; Emily Roumm; Amelia S Geggel; Behzad Moghadaszadeh; Alan H Beggs
Journal:  Hum Mutat       Date:  2010-02       Impact factor: 4.878

10.  Myotubularin-deficient myoblasts display increased apoptosis, delayed proliferation, and poor cell engraftment.

Authors:  Michael W Lawlor; Matthew S Alexander; Marissa G Viola; Hui Meng; Romain Joubert; Vandana Gupta; Norio Motohashi; Richard A Manfready; Cynthia P Hsu; Ping Huang; Anna Buj-Bello; Louis M Kunkel; Alan H Beggs; Emanuela Gussoni
Journal:  Am J Pathol       Date:  2012-07-27       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.